Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 109.09 USD 8.16% Market Closed
Market Cap: 592.4m USD
Have any thoughts about
Mesa Laboratories Inc?
Write Note

Mesa Laboratories Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mesa Laboratories Inc
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Mesa Laboratories Inc
NASDAQ:MLAB
Gross Profit
$142.7m
CAGR 3-Years
16%
CAGR 5-Years
18%
CAGR 10-Years
14%
Becton Dickinson and Co
NYSE:BDX
Gross Profit
$9.2B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Gross Profit
$11B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Gross Profit
$14B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Gross Profit
$23B
CAGR 3-Years
-2%
CAGR 5-Years
5%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Gross Profit
$5.3B
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
14%
No Stocks Found

Mesa Laboratories Inc
Glance View

Market Cap
591.3m USD
Industry
Health Care

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

MLAB Intrinsic Value
119.75 USD
Undervaluation 9%
Intrinsic Value
Price

See Also

What is Mesa Laboratories Inc's Gross Profit?
Gross Profit
142.7m USD

Based on the financial report for Sep 30, 2024, Mesa Laboratories Inc's Gross Profit amounts to 142.7m USD.

What is Mesa Laboratories Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
14%

Over the last year, the Gross Profit growth was 10%. The average annual Gross Profit growth rates for Mesa Laboratories Inc have been 16% over the past three years , 18% over the past five years , and 14% over the past ten years .

Back to Top